GD — General Dynamics Corporation

Q2 beat and guidance raise, record $136.5B backlog, the $29.5B Columbia-class and $42.1B Virginia-class submarine award allocations, and a $1.3B GDIT Army National Guard contract have kept sentiment positive. Wall Street consensus is a Moderate Buy with average targets around $410-$421, while the pullback from $400 reads as consolidation after a strong run rather than fundamental deterioration.

Revenue growth has been consistently solid: YoY growth was +8.1% in Q2 2026, +10.3% in Q1 2026, +7.8% in Q4 2025, +10.6% in Q3 2025, and +8.9% in Q2 2025. EPS growth has been strong in recent quarters: Q2 2026 EPS of $4.25 versus $3.74 (+13.6%) and Q1 2026 EPS of $4.10 versus $3.66 (+12.0%). Operating margin has been stable around 10.0%-10.5%, and gross margin around 15%-16%. Free cash flow has inflected higher: Q1 2026 generated $1.95B versus -$0.29B in Q1 2025, and Q2 2026 generated $1.65B versus $1.40B in Q2 2025. This is a steady growth trend with a cash-flow improvement, not a one-quarter blip.

Expensive relative to its own history. The TTM P/E is 22.85x versus the 5-year average of 20.02x, roughly a 14% premium. P/S is 1.87x versus the 1.64x 5-year average, and PEG is 2.19x. Dividend yield of 1.65% is decent but not a valuation cushion. Even with a record backlog, the current price embeds a high level of execution confidence and offers little margin of safety.

At $380, the market is paying roughly 22.4x next-FY estimated EPS of $16.97, which is only modestly above TTM EPS of $16.61. So the price is not pricing in a near-term earnings acceleration; it is pricing in smooth delivery of the record backlog. If management keeps raising guidance, earnings can grow into the multiple. If submarine or Gulfstream execution slips, the multiple could compress back toward the 20x historical average, putting fair value closer to the mid-$330s to $350 zone.

As of 2026-08-27, RSI was 46.4, which is neutral rather than oversold. Price was 2.0% below the 20-day SMA, 1.2% above the 50-day SMA, and 7.4% above the 200-day SMA. That is a normal pullback within an uptrend, but it is not a screaming buy signal. Waiting for a test of the 50-day SMA would offer a better risk/reward entry.

• Elevated global defense spending and geopolitical instability support multi-year order growth across defense primes.
• U.S. Navy Columbia- and Virginia-class submarine funding provides unusually long revenue visibility for Marine Systems.
• Supply chain and skilled-labor constraints, especially in shipbuilding, create execution and margin risk.
• Interest rates/cost of capital affect P/E multiples, though GD's low beta and government-backed revenue reduce sensitivity.
• Gulfstream's high-end business jet demand is tied to corporate profits and remains cyclically sensitive.

• Q3 2026 earnings in late October 2026: Gulfstream delivery metrics and submarine program progress will be key.
• Continued conversion of the record $136.5B backlog, plus possible additional contract awards or another FY26 guidance raise.
• Quarterly dividend ex-date on October 9, 2026, with a $1.59 per share payout.

• Execution risk at Electric Boat on Columbia/Virginia submarines; cost overruns or schedule slips would pressure Marine Systems margins.
• Valuation risk: at 22.9x TTM EPS, any miss could compress the multiple toward the 20x historical average, implying $330-$350.
• Gulfstream delivery/order cyclicality and supply chain disruptions.
• Combat Systems exposure to shifting U.S. tactical vehicle priorities and program changes.
• Potential future budget/sequestration risk despite currently elevated defense spending.

GD is a high-quality defense and aerospace franchise with record backlog, stable margins, and strong cash generation. But at $380 with a premium multiple and only modest near-term EPS growth, the stock is fairly to fully valued. It is a quality compounder worth owning on pullbacks, not an obvious new buy at this price.

Calculated by applying a justified forward P/E of approximately 21.1x (5-year average P/E of 20.0 plus about one turn for record backlog, stable margins, and low beta) to next-FY estimated EPS of $16.97, yielding roughly $358. This is below the current $380 price, consistent with the rich-vs-own-history valuation read.